Heart rate reduction: an old and novel candidate heart failure therapy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Immune Modulation in Heart Failure: the Promise of Novel Biologics.Current treatment options in cardiovascular medicine · 2018
   Review
2. Heart rate reduction in coronary artery disease and heart failure.Nature reviews. Cardiology · 2016
   Review
3. Heart rate differentiates urgency and emergency in hypertensive crisis.Clinical research in cardiology : official journal of the German Cardiac Society · 2013
   Observational
4. Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation.Circulation research · 2013
   Article

Corrections and comments

• Comment on
  Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and β-receptor blockade.2012

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as